AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
To MELD or not to MELD? Reply
Authors: Kim, WR Kremers, W Kamath, PS Wiesner, RH Malinchoc, M Therneau, TM Dickson, ER
Citation: Wr. Kim et al., To MELD or not to MELD? Reply, HEPATOLOGY, 34(1), 2001, pp. 215-216
A model to predict survival in patients with end-stage liver disease
Authors: Kamath, PS Wiesner, RH Malinchoc, M Kremers, W Therneau, TM Kosberg, CL D'Amico, G Dickson, ER Kim, WR
Citation: Ps. Kamath et al., A model to predict survival in patients with end-stage liver disease, HEPATOLOGY, 33(2), 2001, pp. 464-470
Outcome of hospital care of liver disease associated with hepatitis C in the United States
Authors: Kim, WR Gross, JB Poterucha, JJ Locke, GR Dickson, ER
Citation: Wr. Kim et al., Outcome of hospital care of liver disease associated with hepatitis C in the United States, HEPATOLOGY, 33(1), 2001, pp. 201-206
Bone disease in primary biliary cirrhosis: independent indicators and rateof progression
Authors: Menon, KVN Angulo, P Weston, S Dickson, ER Lindor, KD
Citation: Kvn. Menon et al., Bone disease in primary biliary cirrhosis: independent indicators and rateof progression, J HEPATOL, 35(3), 2001, pp. 316-323
A controlled trial of calcitonin therapy for the prevention of post-liver transplantation atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitis
Authors: Hay, JE Malinchoc, M Dickson, ER
Citation: Je. Hay et al., A controlled trial of calcitonin therapy for the prevention of post-liver transplantation atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitis, J HEPATOL, 34(2), 2001, pp. 292-298
Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease
Authors: Figueiredo, FA Dickson, ER Pasha, TM Porayko, MK Therneau, TM Malinchoc, M DiCecco, SR Francisco-Ziller, NM Kasparova, P Charlton, MR
Citation: Fa. Figueiredo et al., Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease, LIVER TRANS, 6(5), 2000, pp. 575-581
Adaptation of the Mayo primary biliary cirrhosis natural history model forapplication in liver transplant candidates
Authors: Kim, WR Wiesner, RH Poterucha, JJ Therneau, TM Benson, JT Krom, RAF Dickson, ER
Citation: Wr. Kim et al., Adaptation of the Mayo primary biliary cirrhosis natural history model forapplication in liver transplant candidates, LIVER TRANS, 6(4), 2000, pp. 489-494
The timing of liver transplantation in primary biliary cirrhosis
Authors: Angulo, P Dickson, ER
Citation: P. Angulo et Er. Dickson, The timing of liver transplantation in primary biliary cirrhosis, BEST PR RES, 14(4), 2000, pp. 657-668
Timing of liver transplantation
Authors: Kim, WR Dickson, ER
Citation: Wr. Kim et Er. Dickson, Timing of liver transplantation, SEM LIV DIS, 20(4), 2000, pp. 451-464
Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease
Authors: Kim, WR Lindor, KD Malinchoc, M Petz, JL Jorgensen, R Dickson, ER
Citation: Wr. Kim et al., Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease, HEPATOLOGY, 32(5), 2000, pp. 924-929
Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid
Authors: Angulo, P Jorgensen, RA Keach, JC Dickson, ER Smith, C Lindor, KD
Citation: P. Angulo et al., Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid, HEPATOLOGY, 31(2), 2000, pp. 318-323
Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial
Authors: Lindor, KD Jorgensen, RA Tiegs, RD Khosla, S Dickson, ER
Citation: Kd. Lindor et al., Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial, J HEPATOL, 33(6), 2000, pp. 878-882
Impact of nutritional status on outcomes after liver transplantation
Authors: Figueiredo, F Dickson, ER Pasha, T Kasparova, P Therneau, T Malinchoc, M DiCecco, S Francisco-Ziller, N Charlton, M
Citation: F. Figueiredo et al., Impact of nutritional status on outcomes after liver transplantation, TRANSPLANT, 70(9), 2000, pp. 1347-1352
The economic impact of cytomegalovirus infection after liver transplantation
Authors: Kim, WR Badley, AD Wiesner, RH Porayko, MK Seaberg, EC Keating, MR Evans, RW Dickson, ER Krom, RAF Paya, CV
Citation: Wr. Kim et al., The economic impact of cytomegalovirus infection after liver transplantation, TRANSPLANT, 69(3), 2000, pp. 357-361
A revised natural history model for primary sclerosing cholangitis
Authors: Kim, WR Therneau, TM Wiesner, RH Poterucha, JJ Benson, JT Malinchoc, M LaRusso, NF Lindor, KD Dickson, ER
Citation: Wr. Kim et al., A revised natural history model for primary sclerosing cholangitis, MAYO CLIN P, 75(7), 2000, pp. 688-694
Epidemiology and natural history of primary biliary cirrhosis in a US community
Authors: Kim, WR Lindor, KD Locke, GR Therneau, TM Homburger, HA Batts, KP Yawn, BP Petz, JL Melton, LJ Dickson, ER
Citation: Wr. Kim et al., Epidemiology and natural history of primary biliary cirrhosis in a US community, GASTROENTY, 119(6), 2000, pp. 1631-1636
Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis
Authors: Heathcote, EJ Stone, J Cauch-Dudek, K Poupon, R Chazouilleres, O Lindor, KD Petz, J Dickson, ER Poupon, RE
Citation: Ej. Heathcote et al., Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis, LIVER TR S, 5(4), 1999, pp. 269-274
Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization
Authors: Kim, WR Wiesner, RH Poterucha, JJ Therneau, TM Malinchoc, M Benson, JT Crippin, JS Klintmalm, GBG Rakela, J Starzl, TE Krom, RAF Evans, RW Dickson, ER
Citation: Wr. Kim et al., Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization, HEPATOLOGY, 30(2), 1999, pp. 395-400
The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis
Authors: Kim, WR Poterucha, JJ Wiesner, RH LaRusso, NF Lindor, KD Petz, J Therneau, TM Malinchoc, M Dickson, ER
Citation: Wr. Kim et al., The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis, HEPATOLOGY, 29(6), 1999, pp. 1643-1648
Incidence of cancer in primary biliary cirrhosis: The Mayo experience
Authors: Nijhawan, PK Therneau, TM Dickson, ER Boynton, J Lindor, KD
Citation: Pk. Nijhawan et al., Incidence of cancer in primary biliary cirrhosis: The Mayo experience, HEPATOLOGY, 29(5), 1999, pp. 1396-1398
Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis
Authors: Angulo, P Batts, KP Therneau, TM Jorgensen, RA Dickson, ER Lindor, KD
Citation: P. Angulo et al., Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis, HEPATOLOGY, 29(3), 1999, pp. 644-647
Quality of life before and after liver transplantation for cholestatic liver disease
Authors: Gross, CR Malinchoc, M Kim, WR Evans, RW Wiesner, RH Petz, JL Crippin, JS Klintmalm, GB Levy, MF Ricci, P Therneau, TM Dickson, ER
Citation: Cr. Gross et al., Quality of life before and after liver transplantation for cholestatic liver disease, HEPATOLOGY, 29(2), 1999, pp. 356-364
Timing of transplantation for primary biliary cirrhosis - Reply
Authors: Kim, WR Therneau, TM Dickson, ER
Citation: Wr. Kim et al., Timing of transplantation for primary biliary cirrhosis - Reply, HEPATOLOGY, 29(2), 1999, pp. 609-610
Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis
Authors: Pasha, T Heathcote, J Gabriel, S Cauch-Dudek, K Jorgensen, R Therneau, T Dickson, ER Lindor, KD
Citation: T. Pasha et al., Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis, HEPATOLOGY, 29(1), 1999, pp. 21-26
Is routine cholangiography useful in men with suspected primary biliary cirrhosis?
Authors: Weston, SR Jorgensen, RA Dickson, ER Lindor, KD
Citation: Sr. Weston et al., Is routine cholangiography useful in men with suspected primary biliary cirrhosis?, J CLIN GAST, 29(1), 1999, pp. 68-70
Risultati: 1-25 | 26-30